Rewiring DNA circuitry could help treat asthma

July 5, 2012
Dr Rhys Allan from the institute's Molecular Immunology division, was part of a research team that found asthma-promoting immune cells could be rewired so they no longer cause inflammation.

(Medical Xpress) -- Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found.

The researchers were able to reprogram the asthma-promoting cells (called Th2 (T-helper 2) cells) after identifying an enzyme that modifies the DNA of these cells. The enzyme could be a target for the development of new treatments for , in particular , caused by an excess of Th2 cells.

Walter and Eliza Hall Institute researcher Dr Rhys Allan led the research while working at Institut Curie, Paris. The research team from Institut Curie, National Centre for Scientific Research (CNRS), France, National Institute of Health and Medical Research (INSERM), France, and Montpellier Cancer Research Institute published the study today in the journal Nature.

Dr Allan said the research team discovered that the enzyme Suv39h1 could switch off genes to control the function of Th2 cells, which are key to the allergic response.

“Th2 cells have an important function in the immune response, but they also play a significant role in diseases such as allergic asthma,” Dr Allan said. “People with asthma have too many Th2 cells, which produce chemical signals that inflame and damage the upper airways. In this study, we discovered that the Suv39h1 enzyme plays a critical role in programming these asthma-promoting cells, making it a potential target for new therapies to treat asthma.”

More than two million Australians have asthma – approximately one in 10 people – and the disease is even more common among Indigenous Australians. The prevalence of asthma in children in Australia is among the highest in the world.

Dr Allan said the Suv39h1 enzyme was part of the ‘epigenetic circuitry’ of Th2 cells.

“Epigenetics refers to changes or modifications in the DNA that alter how genes are switched on and off, without changing the fundamental DNA sequence. Suv39h1 effectively ‘tags’ the DNA to tell the cells which genes they need to switch on or off to promote an .”

Using agents that inhibit Suv39h1 could destabilise Th2 cells in people who have an excess of these asthma-promoting so they no longer cause inflammation, Dr Allan said.

“We had the idea that erasing these epigenetic tags could ‘short-circuit’ the asthma-promoting and diminish the inflammatory immune response. And, in fact, in mouse models of allergic asthma, blocking this pathway with an inhibitory compound did reduce allergy-related . Ultimately, our results have identified a potential target for therapeutic intervention in asthma and potentially other Th2-mediated inflammatory diseases, which could improve outcomes for patients,” Dr Allan said.

Dr Allan is continuing to study the epigenetic circuitry of asthma-promoting in the institute’s Molecular Immunology division, with funding from the National Health and Medical Research Council of Australia (NHMRC).

The research was supported by Institut Curie, CNRS and INSERM. Dr Allan was funded by an INSERM-NHMRC exchange fellowship.

Explore further: New therapeutic targets for virally-induced asthma attacks suggested

More information: View the journal paper at Nature.

Related Stories

New therapeutic targets for virally-induced asthma attacks suggested

May 29, 2011
When children with asthma get the flu, they often land in the hospital gasping for air. Researchers at Children's Hospital Boston have found a previously unknown biological pathway explaining why influenza induces asthma ...

New findings shift research direction in lupus and asthma

May 29, 2012
(Medical Xpress) -- Newfound details of the immune system suggest a role for never-before-considered drug classes in the treatment of allergic and autoimmune diseases, according to a University of Alabama at Birmingham study ...

Asthma drug discovery

May 22, 2012
(Medical Xpress) -- Researchers from King’s College London have uncovered a new mechanism of action for a group of asthma drugs already on the market, which could enable more effective treatment for patients with a particular ...

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

Regular exercise, stress can both make a big difference in lupus, study finds

September 13, 2017
Waking up in the morning with the joint pain, swelling and stiffness that accompanies lupus doesn't exactly inspire a workout.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.